Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Researchers make neuroblastoma drug target discovery

February 8, 2021 Sales and Marketing Cancer, GOSH, neuroblastoma

Scientists conducting the largest single cell study to date of the childhood cancer neuroblastoma have made a breakthrough in identifying …
News
uk_gov

CureVac enters collaboration with UK government on coronavirus variant vaccines

February 8, 2021 Sales and Marketing COVID-19, CureVac

CureVac has entered a collaboration with the UK government to develop and manufacture potential vaccine candidates against coronavirus variants, with …
News
astrazeneca_building_white

South Africa halts rollout of AstraZeneca’s COVID-19 vaccine amid efficacy concerns

February 8, 2021 Sales and Marketing AstraZeneca, COVID-19

AstraZeneca is racing to adapt its COVID-19 vaccine as new data suggests it offers little protection against the more dominant …
News
image_readtop_2018_569751_15365546683454581

South Korea approves Celltrion’s COVID-19 treatment Regdanvimab for emergency use

February 8, 2021 Sales and Marketing COVID-19, celltrion

The South Korean Ministry of Food and Drug Safety (MFDS) has granted a conditional marketing authorisation (CMA) for the emergency …
News
mark_wilcox_002

Destiny Pharma appoints Professor Mark Wilcox to its Scientific Advisory Board

February 4, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Destiny Pharma, a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life threatening …
Appointment
caroline_oconnor

Raremark appoints Caroline O’Connor as CCO

February 4, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Raremark has appointed Caroline O’Connor as its new Chief Commercial Officer. Previously holding the position of Raremark’s Senior Vice President …
Appointment
philippe_dro

Scenic Biotech appoints Dr Philippe Dro as Chairman

February 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Scenic Biotech has announced the appointment of Dr Philippe Dro as its independent Chairman. Dr Dro replaces Dr Ulrich Grau, …
Appointment

EMA grants marketing authorisation for Amarin’s heart attack treatment

February 1, 2021 Sales and Marketing Amarin, EMA

Amarin have been granted authorisation from the EMA to market a treatment that will reduce the chance of heart attacks …
News

Johnson & Johnson’s single-shot COVID-19 vaccine 85% effective

February 1, 2021 Sales and Marketing COVID-19, Johnson & Johnson, vaccines

Johnson & Johnson has announced that its COVID-19 vaccine candidate is 85% effective in preventing serious symptoms of the disease, …
News
xarelto_10_tablet1

Bayer’s venous thromboembolism drug Xarelto gets UK approval for children

February 1, 2021 Sales and Marketing Bayer

Bayer has received UK approval for the use of its oral Factor Xa inhibitor Xarelto (rivaroxaban) to treat venous thromboembolism …
News
sos002

Sosei Heptares and Metrion Biosciences to collaborate on structure-based drug discovery approaches to ion channels

February 1, 2021 Sales and Marketing Sosei Heptares

Sosei Heptares has announced it will collaborate with Metrion Biosciences, a specialist ion channel CRO and drug discovery company, to …
News
novartis_window

CHMP recommends marketing authorisation for Novartis’ Kesimpta

February 1, 2021 Sales and Marketing Novartis, multiple sclerosis

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended the marketing authorisation of Novartis’ Kesimpta (ofatumumab) for …
News
drug-trials

How COVID-19 has affected the oncology drugs market

January 25, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Cancer

In its disruption to clinical trials and drug supply to patients, the COVID-19 pandemic has impacted the most crucial areas …
Feature

NovAliX and Chemical.AI announce drug discovery collaboration

January 25, 2021 Sales and Marketing Chemical.AI, Novalix

NovAliX, a drug discovery-focused contract research organisation, and Chemical.AI, an artificial intelligence (AI) company, have announced a strategic collaboration in …
News
exelixis

FDA approves Exelixis’ cancer drug Cabometyx

January 25, 2021 Sales and Marketing Cancer, Exelixis

The FDA has approved Exelixis’ Cabometyx (cabozantinib) for patients with advanced renal cell carcinoma (RCC) as a first-line treatment in …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026